Table 5.

Glycemic Status Patients During Alpha Lipoic Acid Treatment

Parameters	Alpha Lipoic Acid
Dose (mg)	400	600	800	1200
Patients	83	78	80	81
M/F	40/43	38/40	39/41	41/40
Smoking status (M/F)	11/13	14/13	12/11	9/11
EU (n; %)	20/22	18/20	16/15	15/14
IFG (n; %)	8/7	8/8	11/10	9/10
IGT (n; %)	14/12	11/13	16/12	18/15
EU from IFG (n; %)	0/0	1/0 (1.3)	2/3 (6.3)	5/6 (13.6)
EU from IGT (n; %)	0/0	0/0	0/1 (1.3)	2/1 (3.7)
IGT from IFG (n: %)	0/0	0/0	0/0	0/0
D from IFG (n; %)	0/0	0/0	0/0	0/0
D from IGT (n; %)	0/0	0/0	0/0	0/0
Lost to FU from IFG (n; %)	0/0	0/0	0/0	0/0
Lost to FU from IGT (n; %)	0/0	0/0	0/0	0/0

Abbreviations: M, males; F, females; IFG, impaired fasting glycemia; IGT, impaired glucose tolerance; EU, euglycemia; D, diabetes; FU, follow-up.